Nebulized Ketamine for the Treatment of Major Depressive Disorder
This is a double-blind active placebo controlled clinical trial for individuals with moderate to severe depression. The purpose of this study is to assess if nebulized ketamine can reduce depressive symptoms.
All individuals 18 years and older with a Montgomery-Asberg Depression Rating Sc... [+2]
Adult patients with an allergy to Ketamine [+14]